Stocktoria
Structure Therapeutics Inc. GPCR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-02-03
Chart by TradingView
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financials | ||||
| Operating income | -$176.6M | -$158.2M | -$102.8M | -$52.6M |
| Net income | -$141.2M | -$122.5M | -$89.6M | -$51.3M |
| Operating cash flow | -$222.2M | -$116.6M | -$79.5M | -$46.1M |
| Free cash flow | -$225.8M | -$117.9M | -$81.7M | -$46.3M |
| Total assets | $1.6B | $903.3M | $482.0M | $97.8M |
| Total liabilities | $67.5M | $38.5M | $29.1M | $13.0M |
| Shareholders' equity | $1.5B | $864.8M | $453.0M | -$115.1M |
| Ratios | ||||
| Return on assets | -8.9% | -13.6% | -18.6% | -52.5% |
| Return on equity | -9.3% | -14.2% | -19.8% | 44.6% |
| Current ratio | 24.81 | 24.74 | 19.14 | 7.16 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 55,800 | $2.7M |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001888886 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.